Abstract Background: In recent years, with the development of transcriptome sequencing, the molecular characteristics of tumors are gradually revealed. Because…
Abstract Simple Summary: Racial disparities in cancer incidence and outcome rates are prevalent in the US, with a variety of…
Abstract Background: Epigenetic reprogramming has been reported to play a critical role in the progression of thyroid cancer. RNA methylation…
Abstract Background: Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) has been reported to exhibit an oncogenic effect as an…
Abstract Background: Immunotherapy using immune checkpoint inhibitors (ICIs), such as antibody of programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) has showed…
Abstract Background: As a crucial constituent part of Polycomb repressive complex 2, PHD finger protein 19 (PHF19) plays a pivotal…
Abstract Background: Immunotherapy is a new and powerful weapon against tumors, represented by inhibitors of programmed death-1 (PD-1) and cytotoxic…
Abstract Purpose: N6-methyladenosine (m6A) methylation plays a critical role in diverse biological processes. However, knowledge regarding the constitution of m6A…
Abstract Background: Human epidermal growth factor receptor (EGFR) is an oncogenic gene and one of top targets of precision therapy…
Abstract Human cancers accumulate various mutations during development and consist of highly heterogeneous cell populations. This phenomenon is called intratumor…